Chavanne David, Ahluwalia Jasjit S, Goodyear Kimberly
Department of Economics, Connecticut College, New London, CT, USA.
Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, Brown University, Providence, RI, USA.
Int J Drug Policy. 2023 Oct;120:104147. doi: 10.1016/j.drugpo.2023.104147. Epub 2023 Aug 26.
With opioid use and overdose rates continuing to plague minority communities in the U.S., we explored whether a geographic community's racial composition and social class affect how opioid use in the community is stigmatized and what policy preferences arise in response.
We use case vignettes in a randomized, between-subjects study (N = 1478) with a nation-wide survey. The vignettes describe a community where opioids are harmfully used, varying whether the community was (1) wealthy or poor, (2) predominantly Black or White and (3) facing prevalent use of painkillers or heroin. We tested how these variables affect public stigmatization of opioid use (measured with ratings of responsibility, dangerousness, sympathy, concern, anger, and disappointment) preferred levels of social distance from communities with opioid use (measured with responses to questions about living, working, and interacting in the community), and policy preferences for responding to opioid use (measured with levels of support for providing a safe-consumption site in the community, treating drug use in the community punitively, treating drug use in the community as an illness, and funding drug treatment in the community through income redistribution).
Compared to wealthy communities with opioid use, poor communities with opioid use were less stigmatized in terms of responsibility, sympathy, concern, anger, and disappointment; they were also met with less support for punitiveness, more support for treating drug use as an illness, and preferences for greater social distance. Compared to White communities with opioid use, Black communities with opioid use were less stigmatized in terms of responsibility, and they were met with stronger preferences to not live and work there and with reduced support for using income redistribution to provide drug treatment for people in the community. Poor-Black communities with opioid use were also perceived to be more dangerous than both poor-White and wealthy-Black communities with opioid use.
These results point to class- and race-based territorial stigma affecting how communities with opioid use are judged and whether policies for providing communities with treatment are supported.
随着阿片类药物的使用和过量使用率持续困扰美国的少数族裔社区,我们探讨了一个地理社区的种族构成和社会阶层如何影响社区内阿片类药物使用的污名化情况,以及相应产生了哪些政策偏好。
我们在一项随机、受试者间研究(N = 1478)中使用案例 vignettes,并进行全国性调查。这些 vignettes 描述了一个阿片类药物被有害使用的社区,社区在以下方面有所不同:(1)富裕或贫穷;(2)主要是黑人或白人;(3)面临止痛药或海洛因的普遍使用。我们测试了这些变量如何影响公众对阿片类药物使用的污名化(通过对责任、危险性、同情、关注、愤怒和失望的评分来衡量)、与使用阿片类药物的社区保持社会距离的偏好程度(通过对关于在该社区生活、工作和互动的问题的回答来衡量),以及应对阿片类药物使用的政策偏好(通过对在社区提供安全消费场所、对社区内药物使用进行惩罚性处理、将社区内药物使用视为一种疾病以及通过收入再分配为社区药物治疗提供资金的支持程度来衡量)。
与有阿片类药物使用情况的富裕社区相比,有阿片类药物使用情况的贫困社区在责任、同情、关注、愤怒和失望方面受到的污名化程度较低;它们在惩罚性方面得到的支持也较少,在将药物使用视为一种疾病方面得到的支持更多,并且对更大社会距离有偏好。与有阿片类药物使用情况的白人社区相比,有阿片类药物使用情况的黑人社区在责任方面受到的污名化程度较低,并且人们更强烈地倾向于不在那里生活和工作,以及在通过收入再分配为社区内人员提供药物治疗方面得到的支持减少。有阿片类药物使用情况的贫困黑人社区也被认为比有阿片类药物使用情况的贫困白人社区和富裕黑人社区更危险。
这些结果表明,基于阶级和种族的地域污名影响着对有阿片类药物使用情况的社区的评判方式,以及为社区提供治疗的政策是否得到支持。